Stage IIIB Breast Cancer Active Not Recruiting Phase 2 Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0028549 (Stage IIIB Breast Cancer)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02311933Tamoxifen Citrate or Z-Endoxifen Hydrochloride in Treating Patients With Locally Advanced or Metastatic, Estrogen Receptor-Positive, HER2-Negative Breast CancerTreatment
NCT02269670Phase II Study of Everolimus Beyond ProgressionTreatment